Open-label Study of ELA026 in Participants With Secondary Hemophagocytic Lymphohistiocytosis (sHLH)
Trial details
- Registry ID
- NCT05416307
- Drugs studied
- ELA026
TrialRedline tracks 1 clinical trial sponsored by Electra Therapeutics Inc.: 1 Phase 2 / 3.
Company identity checked against sources
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| Open-label Study of ELA026 in Participants With Secondary Hemophagocytic Lymphohistiocytosis (sHLH)NCT05416307 | ELA026 | Recruiting | 2028-03Estimated |
Names as written in the registry records.
NCT05416307 · Electra Therapeutics Inc.
Before: Jun 2027. After: Mar 2028.